On the 29th March Almac announced that it has signed an exclusive global distribution deal with Affymetrix, Inc. enabling them to directly sell Almac’s proprietary Xcel™ array for biomarker discovery, development and delivery worldwide.
Almac, a leading provider of contract services to the global Pharmaceutical and Biotech industries, recently enhanced their web based randomization system WebEZ™, and are relauching the product under the new name, aXcess™.
Having identified a business need in the US for a flexible and high quality commercial packaging service provider, the Pharma Services business unit of Almac is proud to expand its established commercial packaging operations with a $10m investment in a new state-of-the-art 100,000ft2 commercial facility in Audubon, PA.
Almac has addressed a surge in clinical outsourcing by acquiring two new pieces of encapsulation equipment at their North American headquarters in Souderton, PA. The Bosch GKF 702 capsule filler with integrated KKE 1700 checkweigher comes as a significant investment for the company close to the one year anniversary of the US headquarters’ grand opening.
Tosoh Bioscience introduces a new reversed phase HPLC column for the separation of intact proteins. TSKgel Protein C4-300 consists of a polymerically bonded butyl (C4) phase on wide pore ultrapure silica.
At the Analytica in Munich Hamilton will present a huge variety of new innovative laboratory products,
Vetter’s 24,000-square-foot site includes microbiology and chemical analysis labs, material preparation and compounding functions, as well as three cleanrooms for aseptic filling. This exceptional facility, situated at the Illinois Science + Technology Park in suburban Chicago, is their first in the U.S.
Vetter received certification for its integrated management system for environmental, health and safety (EHS). The company earned ISO 14001 certification for its environmental management system and BS OHSAS 18001 certification for its occupational health and safety management system.
Hybrigenics, a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus on research and development of new treatments against proliferative diseases and specialized in protein interaction services, today announces its revenues and cash position for the year ended December 31st, 2011.
The Randox liquid ready to use Lipoprotein (a) assay provides a highly sensitive and specific method for the detection of Lp(a) in human serum and plasma. The assay is based on an immunoturbidimetric method and is suitable for use on most chemistry analysers, the assay is not affected by Apo(a) size related bias like other commercially available methods.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.